
    
      In this prospective observational study all cancer patients who are regularly treated in the
      Oncology Outpatient Clinic of the University Medical Center Hamburg-Eppendorf (UKE) will be
      included in the study upon consent.

      Data will be collected as follows:

      (i) Serological antibody screening at study inclusion and every 3 months (ia) In case of
      vaccination monthly screening for 3 months (ii) Routine clinical data: demographic and
      biometric data, medical history, common laboratory parameters (iii) Patient questionnaire:
      assessment of past COVID-19 infection, past COVID-19 specific symptoms, social environment,
      vaccination

      Recruitment is limited to a one-year period (December 2020 - December 2021)
    
  